Cargando…

Patient-related post-ERCP pancreatitis (PEP) risk factors between two groups of patients: Prophylactic pancreatic stent and rectal indomethacin

BACKGROUND: Pancreatitis is one of the most crucial complications following endoscopic retrograde cholangiopancreatography (ERCP). The purpose of the current study was to investigate patient-related post-ERCP pancreatitis (PEP) risk factors in two groups of patients: prophylactic pancreatic stent an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghalehnoei, Hossein, Hormati, Ahmad, Mohammad Alizadeh, Amir Houshang, Ahmadpour, Sajjad, Abedi, Seyed Hassan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Babol University of Medical Sciences 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659831/ https://www.ncbi.nlm.nih.gov/pubmed/36420331 http://dx.doi.org/10.22088/cjim.13.4.728

Ejemplares similares

Underutilization of prophylactic rectal indomethacin and pancreatic duct stent for prevention of post-ERCP Pancreatitis
por: Issak, Abdulfatah, et al.
Publicado: (2021)

Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial
por: Elmunzer, B. Joseph, et al.
Publicado: (2016)

Correction to: Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial
por: Elmunzer, B. Joseph, et al.
Publicado: (2020)

Pancreatic Stent or Rectal Indomethacin—Which Better Prevents Post-ERCP Pancreatitis?: A Propensity Score Matching Analysis
por: Li, Guo-Dong, et al.
Publicado: (2016)

Comparison of stent and indomethacin suppository efficacy in the prevention of acute pancreatitis after ERCP
por: Icacan, Gamze, et al.
Publicado: (2021)

How to select patients and timing for rectal indomethacin to prevent post-ERCP pancreatitis: a systematic review and meta-analysis
por: Wan, Jianhua, et al.
Publicado: (2017)

Is ESR Important for Predicting Post-ERCP Pancreatitis?
por: Mohammad Alizadeh, Amir Houshang, et al.
Publicado: (2015)

Predictors of Post-ERCP Pancreatitis (P.E.P.) in Choledochal Lithiasis Extraction
por: Boicean, Adrian, et al.
Publicado: (2023)

Prevention of post-ERCP pancreatitis: NSAID or pancreatic stent or both?
por: van Wanrooij, R. L. J., et al.
Publicado: (2019)

Comparing the Roles of EUS, ERCP and MRCP in Idiopathic Acute Recurrent Pancreatitis
por: Safari, Mohammad Taghi, et al.
Publicado: (2016)

Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitis
por: Zheng, Minghua, et al.
Publicado: (2008)

Pancreatic Squamous Cell Carcinoma
por: Abedi, Seyed Hassan, et al.
Publicado: (2017)

Pancreatic stenting to prevent post-ERCP pancreatitis: a randomized multicenter trial
por: Phillip, Veit, et al.
Publicado: (2019)

Rectal Indomethacin Prevents Moderate to Severe Post-ERCP Pancreatitis and Death and Should Be Used Before the Procedure: A Meta-Analysis of Aggregate Subgroup Data
por: Yaghoobi, Mohammad, et al.
Publicado: (2018)

Prophylactic Effect of Somatostatin in Preventing Post-ERCP Pancreatitis: An Updated Meta-Analysis
por: Qin, Xie, et al.
Publicado: (2015)

Transabdominal ultrasonography to reduce the burden of X‐ray imaging in prophylactic pancreatic stent localization after ERCP—A prospective trial
por: Michael, Florian Alexander, et al.
Publicado: (2021)

The modified pancreatic stent system for prevention of post-ERCP pancreatitis: a case-control study
por: Zhang, Cheng, et al.
Publicado: (2017)

MRI Evaluation of Indomethacin Suppositories in the Prevention of Complications of Pancreatitis and Hyperamylasemia after Choledocholithiasis ERCP Based on Image Denoising Algorithm
por: Gao, Fusheng, et al.
Publicado: (2022)

Rectal indomethacin reduces the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis in low-risk patients
por: Abdelfatah, Mohamed M., et al.
Publicado: (2020)

Pancreatic Stenting Reduces Post-ERCP Pancreatitis and Biliary Sepsis in High-Risk Patients: A Randomized, Controlled Study
por: Yin, He-Kun, et al.
Publicado: (2016)

Early ERCP in Biliary Pancreatitis?
por: Finch, Margaret D., et al.
Publicado: (1998)

Prevention of Post-ERCP Pancreatitis
por: Donnellan, F., et al.
Publicado: (2012)

Pre-Study protocol MagPEP: a multicentre randomized controlled trial of magnesium sulphate in the prevention of post-ERCP pancreatitis
por: Fluhr, Gabriele, et al.
Publicado: (2013)

Combinatorial Effect of Prophylactic Interventions for Post-ERCP Pancreatitis among Patients with Risk Factors: A Network Meta-Analysis
por: Choi, Jin Ho, et al.
Publicado: (2023)

Rectal indomethacin and diclofenac are equally efficient in preventing pancreatitis following endoscopic retrograde cholangiopancreatography in average‐risk patients
por: Yu, Shuang, et al.
Publicado: (2021)

Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial
por: Smeets, Xavier J. N. M., et al.
Publicado: (2018)

Does Rectal Indomethacin Given for Prevention of Post-ERCP Pancreatitis Increase Bleeding After Biliary Endoscopic Sphincterotomy or Cardiovascular Mortality?: Post Hoc Analysis Using Prospective Clinical Trial Data
por: Patai, Árpád, et al.
Publicado: (2014)

The effect of nafamostat mesilate infusion after ERCP for post-ERCP pancreatitis
por: Kim, Joo Seong, et al.
Publicado: (2022)

Pancreatic stent is the best tool to prevent post-ERCP pancreatitis in high-risk patients: Is the result from recent network meta-analysis valid?
por: Devani, Kalpit, et al.
Publicado: (2020)

ERCP Features and Outcome in Patients with Periampullary Duodenal Diverticulum
por: Mohammad Alizadeh, Amir Houshang, et al.
Publicado: (2013)

Somatostatin administration prior to ERCP is effective in reducing the risk of post-ERCP pancreatitis in high-risk patients
por: ZHAO, LI-NA, et al.
Publicado: (2014)

Adverse events in endoscopic retrograde cholangiopancreaticography (ERCP): Focus on post‐ERCP‐pancreatitis
por: Hollenbach, Marcus, et al.
Publicado: (2022)

Use of NSAIDs via the Rectal Route for the Prevention of Pancreatitis after ERCP in All-Risk Patients: An Updated Meta-Analysis
por: Yu, Lei-Min, et al.
Publicado: (2018)

Rectal Indomethacin Is Protective against Pancreatitis after Endoscopic Retrograde Cholangiopancreatography: Systematic Review and Meta-Analysis
por: He, Xingkang, et al.
Publicado: (2018)

Rectal Indomethacin Does Not Mitigate the Systemic Inflammatory Response Syndrome in Acute Pancreatitis: A Randomized Trial
por: Machicado, Jorge D., et al.
Publicado: (2021)

Evaluation of post-ERCP pancreatitis after biliary stenting with self-expandable metal stents vs. plastic stents in benign and malignant obstructions
por: Martinez, Nichol S., et al.
Publicado: (2021)

ERCP in Evaluating The Mode of Therapy in Pancreatic Pseudocyst
por: Nordback, I., et al.
Publicado: (1988)

ERCP-associated infected intrahepatic pancreatic pseudocyst
por: Angsubhakorn, Natthapon, et al.
Publicado: (2019)

Roles of ERCP in the Early Diagnosis of Pancreatic Cancer
por: Hanada, Keiji, et al.
Publicado: (2019)

Prognosis and risk factors of ERCP pancreatitis in elderly
por: Ergin, Erhan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3ei2j0qfbr3fdfo5lb3m04onl2